ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Mechanisms of Human Plasticity in the Human System

This study has been completed.

Sponsored by: National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001661
  Purpose

The purpose of this study is to investigate the physiology associated with plasticity of the motor system. Plasticity refers to the process by which neighboring brain cells assume the responsibilities of damaged or diseased brain cells.

The mechanisms behind this process are unknown. However, researchers have several theories about how plastic changes take place. Possible explanations include the growth of new connections between brain cells and the use of previously unused connections.

Researchers plan to use transcranial magnetic stimulation and drug intervention in order to determine the mechanisms responsible for specific types of plasticity.

Previous studies have shown that certain drugs can affect the mechanisms involved in these changes. By using one drug at a time, researchers plan to evaluate the role of each of several different mechanisms in brain reorganization.


Condition
Blindness
Cerebrovascular Accident
Spinal Cord Injury

MedlinePlus related topics:   Spinal Cord Injuries   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Mechanisms of Plasticity in the Human Motor System

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   260
Study Start Date:   December 1996
Estimated Study Completion Date:   March 2002

Detailed Description:

The purpose of this study is to investigate the physiology associated with plasticity of the motor system seen in a number of different circumstances. Techniques used will involve the combination of transcranial magnetic stimulation (TMS) and pharmacologic interventions. We propose to use drugs judged to be safe, that either potentiate GABA related intracortical inhibition, change presynaptic release of excitatory aminoacids like glutamate, or decrease the activity of the NMDA receptors (mostly antiepileptic drugs). If plastic changes expressed as larger motor maps or motor evoked potentials (MEP) to TMS are secondary to intracortical disinhibition, administration of a drug that potentiates intracortical inhibition may result in decreased plasticity and smaller motor maps or MEP. This finding would then identify intracortical disinhibition as the mechanism responsible for this type of plasticity. Similarly, if plastic changes decrease with a drug that inhibits release of excitatory aminoacids, or that antagonize the action of NMDA receptors, the mechanism underlying plasticity is likely to be mediated by modulation in the release of excitatory aminoacids or activity in NMDA-receptors.

Results from this study will then provide information about the relative involvement of intracortical disinhibition, modulation in the release of excitatory aminoacids, and role of NMDA receptors in different settings of human plasticity.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Must be over 18 years of age.

Must not have personal history of seizures, loss of consciousness, hypertension, psychosis, heart conditions or allergies to any of the drugs.

Women must not be nursing or pregnant.

Patients may have amputations, spinal cord injuries, blindness or large hemispheric lesions from stroke.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001661

Locations
United States, Maryland
National Institute of Neurological Disorders and Stroke (NINDS)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information

Publications:

Study ID Numbers:   970048, 97-N-0048
First Received:   November 3, 1999
Last Updated:   March 3, 2008
ClinicalTrials.gov Identifier:   NCT00001661
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Plasticity  
Use  
Stroke  
Spinal Cord Injury
Amputation
Intracortical Inhibition

Study placed in the following topic categories:
Sensation Disorders
Vision Disorders
Cerebral Infarction
Spinal Cord Diseases
Eye Diseases
Stroke
Vascular Diseases
Wounds and Injuries
Central Nervous System Diseases
Disorders of Environmental Origin
Blindness
Trauma, Nervous System
Ischemia
Brain Diseases
Cerebrovascular Disorders
Signs and Symptoms
Spinal Cord Injuries
Neurologic Manifestations
Brain Ischemia
Brain Infarction
Infarction

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers